Literature DB >> 1746663

HIV infection and risk behaviors among intravenous drug users in low seroprevalence areas in the Midwest.

H A Siegal1, R G Carlson, R Falck, L Li, M A Forney, R C Rapp, K Baumgartner, W Myers, M Nelson.   

Abstract

We studied behavioral factors that place intravenous drug users at risk for the acquisition and transmission of the human immunodeficiency virus (HIV) in a sample of 855 individuals not in drug treatment, living in central and southwestern Ohio. The HIV seropositivity rate for the sample was 1.5%. Three factors were significantly related to HIV infection: homeless shelter residence (odds ratio [OR] = 7.7, 95% confidence interval (CI) = 3.0-20.0), travel to northeastern HIV hyperendemic areas (OR = 5.2, 95% CI = 1.8-15.4), and recent male homosexual or bisexual behavior (OR = 11.2, 95% CI = 2.9-43.9).

Entities:  

Mesh:

Year:  1991        PMID: 1746663      PMCID: PMC1405293          DOI: 10.2105/ajph.81.12.1642

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  12 in total

1.  The crack life: an ethnographic overview of crack use and sexual behavior among African-Americans in a midwest metropolitan city.

Authors:  R G Carlson; H A Siegal
Journal:  J Psychoactive Drugs       Date:  1991 Jan-Mar

2.  Cocaine use and HIV infection in intravenous drug users in San Francisco.

Authors:  R E Chaisson; P Bacchetti; D Osmond; B Brodie; M A Sande; A R Moss
Journal:  JAMA       Date:  1989-01-27       Impact factor: 56.272

3.  HIV seroprevalence among male IVDUs in Houston, Texas.

Authors:  M L Williams
Journal:  Am J Public Health       Date:  1990-12       Impact factor: 9.308

4.  Prevalence of serum antibody to human immunodeficiency virus among hospitalized intravenous drug abusers in a low-risk geographic area.

Authors:  D Wendt; L Sadowski; N Markowitz; L Saravolatz
Journal:  J Infect Dis       Date:  1987-01       Impact factor: 5.226

5.  Risk factors for human immunodeficiency virus infection among parenteral drug abusers in a low-prevalence area.

Authors:  P H Chandrasekar; J A Molinari; J A Kruse
Journal:  South Med J       Date:  1990-09       Impact factor: 0.954

6.  Geographic distribution of human immunodeficiency virus markers in parenteral drug abusers.

Authors:  W R Lange; F R Snyder; D Lozovsky; V Kaistha; M A Kaczaniuk; J H Jaffe
Journal:  Am J Public Health       Date:  1988-04       Impact factor: 9.308

7.  Human immunodeficiency virus infection among homeless men in a New York City shelter. Association with Mycobacterium tuberculosis infection.

Authors:  R A Torres; S Mani; J Altholz; P W Brickner
Journal:  Arch Intern Med       Date:  1990-10

8.  Risk factors for human immunodeficiency virus infection in intravenous drug users.

Authors:  E E Schoenbaum; D Hartel; P A Selwyn; R S Klein; K Davenny; M Rogers; C Feiner; G Friedland
Journal:  N Engl J Med       Date:  1989-09-28       Impact factor: 91.245

9.  Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York City.

Authors:  M Marmor; D C Des Jarlais; H Cohen; S R Friedman; S T Beatrice; N Dubin; W el-Sadr; D Mildvan; S Yancovitz; U Mathur
Journal:  AIDS       Date:  1987-05       Impact factor: 4.177

Review 10.  Epidemiology of human immunodeficiency virus infection and acquired immunodeficiency syndrome.

Authors:  R L Berkelman; W L Heyward; J K Stehr-Green; J W Curran
Journal:  Am J Med       Date:  1989-06       Impact factor: 4.965

View more
  13 in total

1.  Changes in HIV seroprevalence and related behaviors among male injection drug users who do and do not have sex with men: New York City, 1990-1999.

Authors:  Carey B Maslow; Samuel R Friedman; Theresa E Perlis; Russell Rockwell; Don C Des Jarlais
Journal:  Am J Public Health       Date:  2002-03       Impact factor: 9.308

Review 2.  Social determinants and the health of drug users: socioeconomic status, homelessness, and incarceration.

Authors:  Sandro Galea; David Vlahov
Journal:  Public Health Rep       Date:  2002       Impact factor: 2.792

3.  Sex-specific determinants of HIV infection among injection drug users in Montreal.

Authors:  J Bruneau; F Lamothe; J Soto; N Lachance; J Vincelette; A Vassal; E L Franco
Journal:  CMAJ       Date:  2001-03-20       Impact factor: 8.262

4.  Migration and HIV risk behaviors: Puerto Rican drug injectors in New York City and Puerto Rico.

Authors:  Sherry Deren; Sung-Yeon Kang; Hector M Colón; Jonny F Andia; Rafaela R Robles; Denise Oliver-Velez; Ann Finlinson
Journal:  Am J Public Health       Date:  2003-05       Impact factor: 9.308

Review 5.  Immigration and HIV/AIDS in the New York Metropolitan Area.

Authors:  Michele G Shedlin; Ernest Drucker; Carlos U Decena; Susie Hoffman; Gauri Bhattacharya; Sharlene Beckford; Ricardo Barreras
Journal:  J Urban Health       Date:  2006-01       Impact factor: 3.671

Review 6.  Maintenance of endemicity in urban environments: a hypothesis linking risk, network structure and geography.

Authors:  R Rothenberg
Journal:  Sex Transm Infect       Date:  2007-02       Impact factor: 3.519

7.  Housing instability among people who inject drugs: results from the Australian needle and syringe program survey.

Authors:  Libby Topp; Jenny Iversen; Eileen Baldry; Lisa Maher
Journal:  J Urban Health       Date:  2013-08       Impact factor: 3.671

Review 8.  Barrier methods of contraception, spermicides, and sexually transmitted diseases: a review.

Authors:  L C d'Oro; F Parazzini; L Naldi; C La Vecchia
Journal:  Genitourin Med       Date:  1994-12

9.  The prevalence of homelessness among injection drug users with and without HIV infection.

Authors:  J Y Song; M Safaeian; S A Strathdee; D Vlahov; D D Celentano
Journal:  J Urban Health       Date:  2000-12       Impact factor: 3.671

10.  Traveling young injection drug users at high risk for acquisition and transmission of viral infections.

Authors:  Judith A Hahn; Kimberly Page-Shafer; Jamye Ford; Alan Paciorek; Paula J Lum
Journal:  Drug Alcohol Depend       Date:  2007-11-05       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.